Senior Director
Earl has over 15 years of industry experience, 7 years at 2 research sites as a study coordinator then in operations/business development and 8 years in the CRO space working in feasibility and therapeutic strategy. He has spoken at various industry conferences on CRO-site relations, feasibility best practices, use of real world data in feasibility, and pediatric/rare disease feasibility. Earl’s special interests are in site relationships, real world data, optimizing feasibility, biomarker driven trial enrollment, and pediatric clinical trials.
